1. American College of Chest Physicians and National Heart Lung and Blood Institute national conference on antithrombotic therapy;Dalen, J.E.; Hirsh, J.;Arch Intern Med,1986
2. Intensity of oral anticoagulation in patients monitored with various thromboplastins;Loeliger, L.A.; van den Besselaar, A.M.H.P.; Broekmans, A.W.;N Engl3 Med,1983
3. Thromboplastin-sensitivity, precision and other characteristics. Clin Lab Haenm;Denson, K.W.E.,1988
4. Reliability and clinical impact of the normalisation of the prothrombin times on oral anticoagulant control;Loeliger, E.A.; van den Besselaar, A.M.H.P.; Lewis, S.M.,1985
5. Evaluation of the Ciba Corning Biotrak 512 coagulation monitor for the control of oral anticoagulant therapy;Jennings, I.; Luddington, R.J.; Baglin, T.;Y Clini Pathol,1991